Massachusetts challenges Gilead's hepatitis C drug prices
January 27, 2016 at 10:12 AM EST
Jan 27 (Reuters) - Massachusetts' attorney general is studying whether the prices of Gilead Sciences Inc's blockbuster treatments for hepatitis C violate state law, according to a letter the prosecutor sent to the California drugmaker.
